Phase 2 Study of VGT-309 in Lung Cancer
Clinical trial NCT05400226 · COMPLETED
Trial details
- NCT number
- NCT05400226
- Sponsor
- Vergent Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2023-06-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.